CD19 and acute lymphoblastic leukemia: By simultaneously binding to CD19 on B cells and CD3 on T cells, BLN triggers target cell-dependent T-cell activation, resulting in the cytolysis of CD19<sup>+</sup> BCP-ALL cells.